Literature DB >> 29035968

The final word on nutritional screening and assessment in older persons.

Emanuele Cereda1, Nicola Veronese2,3, Riccardo Caccialanza1.   

Abstract

PURPOSE OF REVIEW: To provide an updated perspective of how nutritional screening and assessment in older persons should be performed and reasonably implemented in the near future. RECENT
FINDINGS: Although nutritional screening and assessment should be fast and easy procedures, there is increasing evidence that more time should be dedicated to them. This is probably an answer to the claim to a medicine being more preventive than curative. Increasing interest is currently given to healthy aging and nutritional status is more likely to be addressed for its implications on functional status and disability. Important prognostic conditions, such as frailty, sarcopenia, and cachexia, which are closely linked to the nutritional domain, are at the top of the agenda. Therefore, body composition is a key issue and functional status is suggested as primary endpoint of nutrition trials. In this scenario, there is also a rationale for systematic assessment of inflammation, protein intake, and vitamin D status as potential contributing factors to reduced muscle mass and function.
SUMMARY: A 'second-generation' multidimensional nutritional screening and assessment including the evaluation of body composition, frailty, sarcopenia, and cachexia could be hypothesized. Nutritional assessment should be also completed by the systematic evaluation of inflammation, protein intake, and vitamin D status.

Entities:  

Mesh:

Year:  2018        PMID: 29035968     DOI: 10.1097/MCO.0000000000000431

Source DB:  PubMed          Journal:  Curr Opin Clin Nutr Metab Care        ISSN: 1363-1950            Impact factor:   4.294


  7 in total

1.  Body composition in amyotrophic lateral sclerosis subjects and its effect on disease progression and survival.

Authors:  Rup Tandan; Evan A Levy; Diantha B Howard; John Hiser; Nathan Kokinda; Swatee Dey; Edward J Kasarskis
Journal:  Am J Clin Nutr       Date:  2022-05-01       Impact factor: 8.472

2.  Predictive Value of Nutritional Risk Screening 2002 and Mini Nutritional Assessment Short Form in Mortality in Chinese Hospitalized Geriatric Patients.

Authors:  Xiaoyan Zhang; Xingliang Zhang; Yunxia Zhu; Jun Tao; Zhen Zhang; Yue Zhang; Yanyan Wang; YingYing Ke; ChenXi Ren; Jun Xu
Journal:  Clin Interv Aging       Date:  2020-03-20       Impact factor: 4.458

3.  Association of Lower Nutritional Status and Education Level with the Severity of Depression Symptoms in Older Adults-A Cross Sectional Survey.

Authors:  Zuzanna Chrzastek; Agnieszka Guligowska; Bartlomiej Soltysik; Malgorzata Pigłowska; Ewa Borowiak; Joanna Kostka; Tomasz Kostka
Journal:  Nutrients       Date:  2021-02-04       Impact factor: 5.717

4.  Skeletal Muscle Mass, Sarcopenia and Rehabilitation Outcomes in Post-Acute COVID-19 Patients.

Authors:  Michele Gobbi; Emanuela Bezzoli; Francesco Ismelli; Giulia Trotti; Stefano Cortellezzi; Francesca Meneguzzo; Marco Arreghini; Ionathan Seitanidis; Amelia Brunani; Valentina Aspesi; Veronica Cimolin; Paolo Fanari; Paolo Capodaglio
Journal:  J Clin Med       Date:  2021-11-29       Impact factor: 4.241

Review 5.  Whey Protein, Leucine- and Vitamin-D-Enriched Oral Nutritional Supplementation for the Treatment of Sarcopenia.

Authors:  Emanuele Cereda; Roberto Pisati; Mariangela Rondanelli; Riccardo Caccialanza
Journal:  Nutrients       Date:  2022-04-06       Impact factor: 5.717

6.  Nutritional Risk Screening Tools for Older Adults with COVID-19: A Systematic Review.

Authors:  David Franciole Oliveira Silva; Severina Carla Vieira Cunha Lima; Karine Cavalcanti Mauricio Sena-Evangelista; Dirce Maria Marchioni; Ricardo Ney Cobucci; Fábia Barbosa de Andrade
Journal:  Nutrients       Date:  2020-09-27       Impact factor: 5.717

Review 7.  Nutrition and Healthy Aging: Prevention and Treatment of Gastrointestinal Diseases.

Authors:  Neri Maria Cristina; d'Alba Lucia
Journal:  Nutrients       Date:  2021-11-30       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.